10% Owner Jack Schuler Buys $903K in Biodesix Stock Following Positive Financials
BDSX has more than doubled off its 52-week low of $3.436 on light trading volume (0.4× avg).
Summary
A 10% owner of Biodesix, Jack W. Schuler, purchased over $900,000 worth of company stock in an open market transaction, indicating significant insider confidence.
Key Events · Ownership and Investor Activity · BDSX
-
Significant Insider Purchase
Jack W. Schuler, a 10% owner, acquired 82,465 shares of common stock for a total value of $903,561 on January 22, 2026.
-
Substantial Investment
The purchase represents a notable investment, signaling strong confidence from a major shareholder in the company's prospects.
-
Follows Positive Financials
This insider buying activity comes shortly after Biodesix reported preliminary Q4 and full-year 2025 revenues that exceeded expectations on January 12, 2026.
Analysis · BDSX · Industrial Applications And Services
Jack W. Schuler, a 10% owner of Biodesix, made a substantial open market purchase of the company's common stock, investing over $900,000. This significant insider buying activity, representing nearly 1% of the company's market capitalization, signals strong confidence from a major shareholder. The purchase follows the company's recent preliminary unaudited financial results for Q4 and full-year 2025, which reported revenue exceeding expectations, suggesting Schuler's investment aligns with a positive outlook on the company's performance.
How filings like this one have moved
In the 30 days to Sep 15, 2026, 29.9% of the 1678 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.25%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BDSX was trading at $11.78 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $93.4M. The 52-week trading range was $3.44 to $21.80. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.